Table 2.

Initiation of Lipid-Lowering Medications/Supplements in Children With and Without Hypercholesterolemia ^a

	Total	Hypercholesterolemia				No high cholesterolb N=(2239)
		Prevalent (N=342)c		Incident (N=282)d
Medication or Supplement	N	Before Study Entry	After Study Entry	Before Event	After Event
Statins	26	0	3	1	15e	7
Bile acid sequestrants	9	1	0	1	0	7
Fibrates	9	0	2	1	2	4
Niacin	2	0	0	0	1f	1g
Omega-3 fatty acids	3	0	2	0	0	1
Other medications	2	0	0	0	0	2h

^aThese data represent the first reported date of use of each of these medications or supplements for each participant

^bThese children did not have prevalent or incident hypercholesterolemia by the definitions used in this study.

^cThis includes all prevalent cases, regardless of duration of follow-up.

^dThis includes all incident cases, regardless of duration of follow-up.

^eOne child was on statins, but the start date was not given. So, we assumed that statins were started after hypercholesterolemia.

^fThe child was on niacin tablets (nicotinic acid)

^gThe child was on niacin as an antilipemic agent

^hOne child was on Clopidogrel bisulfate and one child was on DH-581/probucol